Probably not going to happen. They have every intent to expand labs and becoming compliant going forward. Debt is under control as long as revenues increase.
I was thinking so myself but i see that the open debt is worth about 1 million shares. The 6 million in cash was 'more expensive' debt so I think I'd rather see them cashed in with the notion that other than equity funding.... We are done printing shares.
I'd rather see $1M equity funding go towards the CO lab rather than print off more notes for that.